NCT04478097View on ClinicalTrials.gov

Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

November 5, 2020

Study Completion Date

January 1, 2021

Conditions
Cardiovascular Disease
Interventions
DRUG

CKD-330 Tab. and D086 Tab.

1T

DRUG

CKD-333 Tab.

1T

Trial Locations (1)

Unknown

Jang Hee Hong, Daejeon

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY